Comparison
1q24q25 Microdeletion Syndrome Cn252652 vs 13q12 3 Microdeletion Syndrome C4750951
Clinical comparison between 1q24q25 Microdeletion Syndrome CN252652 and 13q12 3 Microdeletion Syndrome for differential diagnosis and treatment planning.
1q24q25 Microdeletion Syndrome Cn252652
A genetic condition involving deletion of material from chromosome 1. Leads to developmental delays, growth issues, and various medical concerns. Treatment addresses individual symptoms.
13q12 3 Microdeletion Syndrome C4750951
A rare genetic condition where a small piece of chromosome 13 is missing. It can cause various developmental and medical concerns. Care is supportive and tailored to the individual's needs.
6 comparison axes
Onset
1q24q25 Microdeletion Syndrome Cn252652
Variable
13q12 3 Microdeletion Syndrome C4750951
0-null
Onset patterns differ
Severity
1q24q25 Microdeletion Syndrome Cn252652
severe
13q12 3 Microdeletion Syndrome C4750951
moderate
Different severity levels
Chronic
1q24q25 Microdeletion Syndrome Cn252652
Chronic
13q12 3 Microdeletion Syndrome C4750951
Chronic
Differing course
Communicable
1q24q25 Microdeletion Syndrome Cn252652
No
13q12 3 Microdeletion Syndrome C4750951
No
Different transmission
Body System
1q24q25 Microdeletion Syndrome Cn252652
congenital
13q12 3 Microdeletion Syndrome C4750951
congenital
Same/different system
Category
1q24q25 Microdeletion Syndrome Cn252652
rare-disease
13q12 3 Microdeletion Syndrome C4750951
genetic
Different category
Bottom line
1q24q25-microdeletion-syndrome-CN252652 and 13q12-3-microdeletion-syndrome-C4750951 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 1q24q25 Microdeletion Syndrome Cn252652 | 13q12 3 Microdeletion Syndrome C4750951 | Discriminating power |
|---|---|---|---|
| Developmental concerns | Developmental delay is described. | Developmental concerns are possible but unspecified. | Low |
| Growth | Growth issues are specifically mentioned. | Growth effects are not established here. | Moderate |
| Severity label | Source label is severe, not an individual prognosis. | Source label is moderate, not an individual prognosis. | Low |
When to favor each condition
Choose 1q24q25 Microdeletion Syndrome Cn252652 when
A laboratory report confirms a 1q24q25 deletion
The chromosomal locus defines this condition more reliably than symptoms.
High
Developmental delay occurs with growth concerns
This combination fits the supplied description but is not specific.
Low
Recognition occurs at a variable age
Variable onset is reported, so timing alone is not discriminatory.
Low
Choose 13q12 3 Microdeletion Syndrome C4750951 when
A laboratory report confirms a 13q12.3 deletion
The documented chromosome 13 locus distinguishes it from a chromosome 1 deletion.
High
Developmental or medical concerns lack a specified growth pattern
This is compatible with the sparse description but does not confirm it.
Low
Onset information is unavailable
The supplied onset value is unclear and should not be used for classification.
Low
How key tests differ
| Test | 1q24q25 Microdeletion Syndrome Cn252652 | 13q12 3 Microdeletion Syndrome C4750951 | Interpretation |
|---|---|---|---|
| Chromosomal microarray | Deletion involving 1q24q25. | Deletion involving 13q12.3. | Locus and reported breakpoints distinguish them; gene content needs the laboratory report. |
| Karyotype | A small deletion may not be visible. | A small deletion may not be visible. | A normal karyotype does not exclude either condition. |
| Clinical genetics review | Findings are correlated with the individual deletion. | Findings are correlated with the individual deletion. | Neither result alone establishes complications or prognosis. |
Prognosis comparison
1q24q25 Microdeletion Syndrome Cn252652
- Outcome
- Long-term outcome is not established; the source labels it severe.
- Factors
- Deletion details, developmental delay, and growth issues may be relevant.
13q12 3 Microdeletion Syndrome C4750951
- Outcome
- Long-term outcome is not established; the source labels it moderate.
- Factors
- Deletion details and individual developmental or medical findings may be relevant.
Time frame: Both are described as chronic, but the course is not precisely established.
Breakpoints, involved genes, and clinical findings require specialist interpretation.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental needs | Delay is described; specific domains are not. Developmental concerns are possible but unspecified. Type and severity are not established from the supplied data. |
| Growth or medical problems | Growth issues and varied medical concerns are mentioned. Varied medical concerns are mentioned without specifics. No definitive complication list is supported here. |
| Associated congenital anomalies | Not specifically established. Not specifically established. Targeted evaluation should be individualized by clinicians. |
Patient education highlights
- HighDiagnostic confirmation
The condition depends on a documented deletion and professional interpretation, not symptoms alone.
- HighIndividualized care
Care is supportive and tailored; no universal treatment or dose is established here.
- MediumInheritance and transmission
Neither condition is communicable. Family implications require genetic counseling.